Stay updated on Isatuximab for High-Risk Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.

Latest updates to the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page
- Check4 days agoChange DetectedA notice about NIH terminology during the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the website revision advances from v3.7.1 to v3.7.2.SummaryDifference0.5%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new study-record version was posted on 2026-10-06, documenting a change to the study’s status.SummaryDifference0.3%

- Check39 days agoChange DetectedAdded a new revision entry 'Revision: v3.7.0' to the study record history and removed the previous entry 'Revision: v3.6.6'. This updates the visible revision history to reflect the latest modification to the trial record.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history, and the previous v3.6.5 entry was removed. This updates the record’s version history rather than altering study content.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision entry v3.6.5 was added to the study's history, and the previous entry v3.6.4 was removed, updating the documented version history. This reflects an update to the audit trail of the trial record.SummaryDifference0.1%

- Check89 days agoChange DetectedA new revision entry (v3.6.4) was added to the record history and the previous revision (v3.6.3) was removed, indicating an administrative update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to Isatuximab for High-Risk Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.